Biotech star company Biosis Healing ranked in the list of “Top 100 Potential Companies in Sci-Tech Innovation Board”

by

On January 16, 2019, the "New Era of Capital Market-Sci-Tech Innovation Board Seminar" hosted by Sina Finance was held in Beijing. At this meeting, the "Top 100 Potential Companies in Sci-Tech Innovation Board" was announced, and Beijing Biosis Healing Biological Technology Co., Ltd. was successfully selected. Selected in the "Top 100 Potential Companies in Sci-Tech Innovation Board" list further demonstrates the extensive recognition of Biosis Healing in the technology industry and professional institutions.

Looking back, Achieving great achievements

Behind this achievement is the continuous innovation of Biosis Healing. In the past two years, Biosis Healing has continuously explored and tried in development, especially in the field of scientific and technological innovation. Based on the core technology system, it has developed 20 surgical repair implant products and more than 20 minimally invasive surgical instruments. Many products are domestically initiated or included in the national key R&D program. 

Around the major surgical fields such as abdominal surgery, gastrointestinal surgery, neurosurgery, maxillofacial surgery, orthopedics, thoracic surgery, otolaryngology, etc., we have launched biological hernia patches, anastomosis reinforcement patches, biological dura mater, anal fistula plug, biological tendon repair matrix, biological ear patch and a series of implant regeneration products and innovative minimally invasive surgical instruments. The company provides comprehensive solutions for tissue repair and functional regeneration and becomes a platform-type enterprise for surgical implant devices.

In the future, Biosis Healing also hopes to use the power of its own technology to bring qualitative changes to the lives and health of more people, continue to inject new vitality into the biotechnology industry, and continue to practice overall solutions of innovative and high-quality surgical treatment, to achieve corporate vision of make outstanding contributions to global great health in the field of biotechnology.